Ipsogen has launched MapQuant Dx HER2 test. Developed on the MapQuant Dx microarray diagnostic platform, MapQuant Dx HER2 measures a set of HER2-amplified genes that correlate with HER2 protein expression. This new HER2 test provides reliable, intelligible and decisive information for pathologists, oncologists and patients.
Advanced Instruments has been a leading developer and manufacturer of analytical instruments and services for the clinical, biopharmaceutical, and food & beverage industries for more than 65 years. Globally, we provide innovative technologies aligned with the needs of the markets we serve, helping to improve efficiency, enhance productivity, and...
Hyatt Regency, Vancouver, Canada
19-23 November, 2024
Hilton London Metropole, 255 Edgware Road, London, W2 1JU
11-12 December, 2024
Liverpool Arena and Convention Centre
31 March - 3 April, 2025
RAF Museum, Hendon, London NW9 5LL
15 May, 2025
ICC Ghent, Belgium
24-26 June, 2025
